N/A
N=10
VisionRT-based Deep Inspiration Breath-hold (DIBH) Respiratory Motion Management Strategy, A Pilot Study for Thoracic and Abdominal Tumors
Thoracic Cancer · Abdominal Cancer
Bottom Line
View on ClinicalTrials.gov: NCT04686500 ↗Enrolled (actual)
10
Serious AEs
—
Results posted
Nov 2024
Primary outcome: Primary: Correlation Between Kilovoltages X-ray Images of the Diaphragm and the Surface Guided Motion Analyzed With Matlab — 0.01; 0.07 correlation coefficient
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Tidal volume measured by spirometer and DIBH surface from CT image (Device)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Texas Southwestern Medical Center
- Primary completion
- Jul 2021
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Correlation Between Kilovoltages X-ray Images of the Diaphragm and the Surface Guided Motion Analyzed With Matlab |
0.01; 0.07 | — |
| SECONDARY Target Margin Contingency Table Based on Surface and Diaphragm Motion |
16172; 2161; 428; 92; 26; 14 | — |
Summary
A more recent competing technology for implementing the DIBH technique is real-time surface photogrammetry using the AlignRT system (Vision RT Ltd., London, UK). AlignRT system use non-ionization near infrared light to track patient surface motion. The system has one projector projecting near infrared optical pattern on patient surface. The optical pattern is imaged by optical cameras (two per pod) at ~25 Hz. The user selects a region-of-interest (ROI) on the surface and the software calculates and displays the real-time position in six degrees (3 translations and 3 rotations) in real-time. Once the patient has matched the pre-determined DIBH position (within threshold accuracy), the radiation beam is enabled to be turned on for treatment.
Eligibility Criteria
Inclusion Criteria
- Patients must be willing and capable to provide informed consent to participate in the protocol.
- Patient with presumed pulmonary function capable of holding breath for at least 30 seconds - later to be confirmed.
- All men, as well as women of child-bearing potential must agree to use adequate contraception (hormonal or barrier method of birth control; abstinence) prior to study entry, and until study imaging is complete. Should a woman become pregnant or suspect she is pregnant while participating in this study, she should inform her treating physician immediately.
3.1 A female of child-bearing potential is any woman (regardless of sexual orientation, marital status, having undergone a tubal ligation, or remaining celibate by choice) who meets the following criteria:
- Has not undergone a hysterectomy or bilateral oophorectomy; or
- Has not been naturally postmenopausal for at least 12 consecutive months (i.e., has had menses at any time in the preceding 12 consecutive months).
3.2 Patients must be compliant to all required pretreatment evaluations
Exclusion Criteria
- Pregnant or lactating women, as treatment involves unforeseeable risks to the embryo or fetus
- Patients are not compliant to all required pretreatment evaluations
Data sourced from ClinicalTrials.gov (NCT04686500). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.